[HTML][HTML] Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
Purpose Dexamethasone is the only drug that has consistently reduced mortality in patients
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19.
LF Reyes, A Rodriguez, A Bastidas… - Journal of Critical …, 2022 - europepmc.org
Purpose Dexamethasone is the only drug that has consistently reduced mortality in patients
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
LF Reyes, A Rodriguez, A Bastidas… - Journal of critical …, 2022 - docusalut.com
Dexamethasone is the only drug that has consistently reduced mortality in patients with
COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
[引用][C] Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
LF Reyes, A Rodriguez, A Bastidas… - … of Critical Care, 2022 - produccioncientifica.uca.es
Purpose: Dexamethasone is the only drug that has consistently reduced mortality in patients
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
LF Reyes, A Rodriguez, A Bastidas… - … of critical care, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose Dexamethasone is the only drug that has consistently reduced mortality in patients
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
[HTML][HTML] Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
LF Reyes, A Rodriguez, A Bastidas… - Journal of Critical …, 2022 - ncbi.nlm.nih.gov
Purpose Dexamethasone is the only drug that has consistently reduced mortality in patients
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
LF Reyes, A Rodriguez, A Bastidas, D Parra Tanoux - intellectum.unisabana.edu.co
Purpose: Dexamethasone is the only drug that has consistently reduced mortality in patients
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19.
LF Reyes, A Rodriguez, A Bastidas… - Journal of Critical …, 2022 - europepmc.org
Purpose Dexamethasone is the only drug that has consistently reduced mortality in patients
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
with COVID-19, especially in patients needing oxygen or invasive mechanical ventilation …
[引用][C] Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
LF Reyes, A Rodriguez, A Bastidas… - … of Critical Care, 2022 - produccioncientifica.uca.es